Search research articles
Contact Us
Filters
Showing results (591-600 of 612) with videos related to
Page
of 62
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 20, 2015
Phase I Study of Vorinostat as a Radiation Sensitizer with 131I-Metaiodobenzylguanidine (131I-MIBG) for Patients with Relapsed or Refractory Neuroblastoma
Steven G DuBois, Susan Groshen, Julie R Park, et al.
The New England Journal of Medicine
|
October 1, 2010
Anti-GD2 antibody with GM-CSF, interleukin-2, and isotretinoin for neuroblastoma
Alice L Yu, Andrew L Gilman, M Fevzi Ozkaynak, et al.
Oncotarget
|
February 22, 2018
MYC-family protein overexpression and prominent nucleolar formation represent prognostic indicators and potential therapeutic targets for aggressive high-MKI neuroblastomas: a report from the children's oncology group
Risa Niemas-Teshiba, Ryosuke Matsuno, Larry L Wang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 15, 2022
Outcomes Following GD2-Directed Postconsolidation Therapy for Neuroblastoma After Cessation of Random Assignment on ANBL0032: A Report From the Children's Oncology Group
Ami V Desai, Andrew L Gilman, Mehmet Fevzi Ozkaynak, et al.
Journal of Medical Internet Research
|
March 16, 2021
Underrepresentation of Phenotypic Variability of 16p13.11 Microduplication Syndrome Assessed With an Online Self-Phenotyping Tool (Phenotypr): Cohort Study
Jianqiao Li, Margaret A Hojlo, Sampath Chennuri, et al.
Eclinicalmedicine
|
April 24, 2023
Regorafenib plus nivolumab in patients with mismatch repair-proficient/microsatellite stable metastatic colorectal cancer: a single-arm, open-label, multicentre phase 2 study
Marwan Fakih, Kanwal Pratap Singh Raghav, David Z Chang, et al.
Scientific Data
|
March 27, 2020
Epidemiological data from the COVID-19 outbreak, real-time case information
Bo Xu, Bernardo Gutierrez, Sumiko Mekaru, et al.
Journal of the National Cancer Institute
|
July 30, 2011
ABCC multidrug transporters in childhood neuroblastoma: clinical and biological effects independent of cytotoxic drug efflux
Michelle J Henderson, Michelle Haber, Antonio Porro, et al.
Pediatric Blood & Cancer
|
June 30, 2012
Peripheral neuroblastic tumors with genotype-phenotype discordance: a report from the Children's Oncology Group and the International Neuroblastoma Pathology Committee
Rie Suganuma, Larry L Wang, Hideki Sano, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 16, 2022
Long-Term Morbidity and Mortality Among Survivors of Neuroblastoma Diagnosed During Infancy: A Report From the Childhood Cancer Survivor Study
Danielle Novetsky Friedman, Pamela J Goodman, Wendy M Leisenring, et al.
Page
of 62
Search research articles
Search
Showing results (591-600 of 612) with videos related to
Sort By:
Page
of 62
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 20, 2015
Phase I Study of Vorinostat as a Radiation Sensitizer with 131I-Metaiodobenzylguanidine (131I-MIBG) for Patients with Relapsed or Refractory Neuroblastoma
Steven G DuBois, Susan Groshen, Julie R Park, et al.
The New England Journal of Medicine
|
October 1, 2010
Anti-GD2 antibody with GM-CSF, interleukin-2, and isotretinoin for neuroblastoma
Alice L Yu, Andrew L Gilman, M Fevzi Ozkaynak, et al.
Oncotarget
|
February 22, 2018
MYC-family protein overexpression and prominent nucleolar formation represent prognostic indicators and potential therapeutic targets for aggressive high-MKI neuroblastomas: a report from the children's oncology group
Risa Niemas-Teshiba, Ryosuke Matsuno, Larry L Wang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 15, 2022
Outcomes Following GD2-Directed Postconsolidation Therapy for Neuroblastoma After Cessation of Random Assignment on ANBL0032: A Report From the Children's Oncology Group
Ami V Desai, Andrew L Gilman, Mehmet Fevzi Ozkaynak, et al.
Journal of Medical Internet Research
|
March 16, 2021
Underrepresentation of Phenotypic Variability of 16p13.11 Microduplication Syndrome Assessed With an Online Self-Phenotyping Tool (Phenotypr): Cohort Study
Jianqiao Li, Margaret A Hojlo, Sampath Chennuri, et al.
Eclinicalmedicine
|
April 24, 2023
Regorafenib plus nivolumab in patients with mismatch repair-proficient/microsatellite stable metastatic colorectal cancer: a single-arm, open-label, multicentre phase 2 study
Marwan Fakih, Kanwal Pratap Singh Raghav, David Z Chang, et al.
Scientific Data
|
March 27, 2020
Epidemiological data from the COVID-19 outbreak, real-time case information
Bo Xu, Bernardo Gutierrez, Sumiko Mekaru, et al.
Journal of the National Cancer Institute
|
July 30, 2011
ABCC multidrug transporters in childhood neuroblastoma: clinical and biological effects independent of cytotoxic drug efflux
Michelle J Henderson, Michelle Haber, Antonio Porro, et al.
Pediatric Blood & Cancer
|
June 30, 2012
Peripheral neuroblastic tumors with genotype-phenotype discordance: a report from the Children's Oncology Group and the International Neuroblastoma Pathology Committee
Rie Suganuma, Larry L Wang, Hideki Sano, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 16, 2022
Long-Term Morbidity and Mortality Among Survivors of Neuroblastoma Diagnosed During Infancy: A Report From the Childhood Cancer Survivor Study
Danielle Novetsky Friedman, Pamela J Goodman, Wendy M Leisenring, et al.
Page
of 62